Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Zilico Ltd has received EC certification from its Notified Body for its cervical cancer diagnostics device, ZedScan I.
The UK company's ground-breaking system offers quicker and more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management.
The ZedScan I system is used alongside colposcopy on women identified with an abnormal smear result. ZedScan offers clinical benefits by identifying the optimum biopsy site and so reducing the number of cervical biopsies required whilst also facilitating a wider use of 'select & treat'.
As well as its clinical benefits, a recent independent health economics report demonstrated that ZedScan delivers cost-effective benefits to healthcare systems.
Zilico's patented Electrical Impedance Spectroscopy (EIS) technology exploits the different electrical resistivity of normal, pre-cancerous and cancerous tissue.
The system, which is both safe and painless, consists of a portable hand-held device and docking station, software application and a single-use EIS sensor. Five clinical trials in the UK and EU have supported the clinical efficacy of ZedScan, including a pivotal European trial of 429 women in 2011 across three hospitals in the UK and Ireland.
The company has been presenting these results at key scientific meetings and high-profile healthcare conferences across the world, including ASCCP 2012 at which it received the 'Best Scientific Presentation' award.
Following EC certification, ZedScan is being introduced into a number of clinics in the UK and healthcare systems across the globe.
Sameer Kothari, Chief Executive of Zilico Ltd, said: "ZedScan has the potential to make a significant impact on how women are managed within the cervical cancer pathway by providing better information to the clinician in real-time and its European approval is an important advancement for clinicians, healthcare systems and patients.
ZedScan has generated substantial interest from clinicians across the globe through various presentations, conferences and clinical meetings and we now look forward to being able to satisfy the growing demand as colposcopy clinics seek to implement this breakthrough system and exploit the clinical and health economic benefits it will bring through better patient management."
Zilico Ltd was spun out of the University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust. Professor John Tidy, a Consultant Gynaecological Oncologist at the Royal Hallamshire Hospital Sheffield, co-founded the Company with Professor Brian Brown, from the University of Sheffield's Department of Cardiovascular Science, with his early development work on Electrical Impedance Spectroscopy (EIS).
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Cervical Cancer / HPV Vaccine category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Ltd, Zilico. "Zilico's cervical cancer diagnostic device lands CE Mark." Medical News Today. MediLexicon, Intl., 7 Oct. 2013. Web.
8 Dec. 2013. <http://www.medicalnewstoday.com/releases/267031>
Ltd, Z. (2013, October 7). "Zilico's cervical cancer diagnostic device lands CE Mark." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/267031.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.